Atomoxetine in adults with ADHD: two randomized, placebo-controlled studies
Top Cited Papers
- 1 January 2003
- journal article
- research article
- Published by Elsevier in Biological Psychiatry
- Vol. 53 (2) , 112-120
- https://doi.org/10.1016/s0006-3223(02)01671-2
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Once-Daily Atomoxetine Treatment for Children and Adolescents With Attention Deficit Hyperactivity Disorder: A Randomized, Placebo-Controlled StudyAmerican Journal of Psychiatry, 2002
- Atomoxetine Increases Extracellular Levels of Norepinephrine and Dopamine in Prefrontal Cortex of Rat A Potential Mechanism for Efficacy in Attention Deficit/Hyperactivity DisorderNeuropsychopharmacology, 2002
- Atomoxetine in the Treatment of Children and Adolescents With Attention-Deficit/Hyperactivity Disorder: A Randomized, Placebo-Controlled, Dose-Response StudyPediatrics, 2001
- Evidence for co-release of noradrenaline and dopamine from noradrenergic neurons in the cerebral cortexMolecular Psychiatry, 2001
- A Controlled Clinical Trial of Bupropion for Attention Deficit Hyperactivity Disorder in AdultsAmerican Journal of Psychiatry, 2001
- Age-Dependent Decline of Symptoms of Attention Deficit Hyperactivity Disorder: Impact of Remission Definition and Symptom TypeAmerican Journal of Psychiatry, 2000
- Attention deficit hyperactivity disorder adults: Comorbidities and adaptive impairmentsComprehensive Psychiatry, 1996
- Hyperactivity at Adolescence: Some Misconceptions and New DirectionsJournal of Clinical Child Psychology, 1986
- Review of follow-up and follow-back studies of childhood hyperactivity.Psychological Bulletin, 1984
- A RATING SCALE FOR DEPRESSIONJournal of Neurology, Neurosurgery & Psychiatry, 1960